feed,title,long_url,short_url
Benzinga,Ascentage Pharma Enters into an Agreement with University of Michigan to obtain an exclusive license for a MDM2 Degrader using PROTAC Technology,https://www.benzinga.com/pressreleases/20/11/n18566490/ascentage-pharma-enters-into-an-agreement-with-university-of-michigan-to-obtain-an-exclusive-licen,https://j.mp/3fQ5Wbe
